Medical therapy doses at hospital discharge in patients with existing and de novo heart failure

ConclusionsIn a single ‐region experience of hospitalized HFrEF patients, a high proportion of eligible patients were discharged on ACE‐I/ARB or beta‐blocker. Less than half were prescribed MRAs, and few were prescribed ≥50% or target dosing of all medications. Further exploration into barriers to medication uptit ration, and improvement in processes of care, is needed.

Source: ESC Heart Failure - June 19, 2019 Category: Cardiology Authors: Michael J. Diamant, Sean A. Virani, Winston J. MacKenzie, Andrew Ignaszewski, Mustafa Toma, Nathaniel M. Hawkins Tags: Original Research Article Source Type: research